| For: | Chen WC, Liu Q, Fu JX, Kang SY. Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 2004; 10(19): 2886-2889 [PMID: 15334693 DOI: 10.3748/wjg.v10.i19.2886] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/2886.htm |
| Number | Citing Articles |
| 1 |
Yu Lei, Zhang Geng, Wu Guo-Jun, Wang He, Yuan Jian-Lin. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance. Molecular and Cellular Biochemistry 2010; 344(1-2) doi: 10.1007/s11010-010-0525-3
|
| 2 |
Marian Adamkov, Desanka Výbohová, Veronika Tupá, Jaroslava Chylíková, Jaroslav Horáček, Marián Benčat. Expression and significance of survivin in colorectal high grade and low grade adenomas. Acta Histochemica 2015; 117(6) doi: 10.1016/j.acthis.2015.05.006
|
| 3 |
Romain Mathieu, Ilaria Lucca, Mihai D. Vartolomei, Aurélie Mbeutcha, Tobias Klatte, Christian Seitz, Pierre I. Karakiewicz, Harun Fajkovic, Maxine Sun, Yair Lotan, Francesco Montorsi, Alberto Briganti, Morgan Rouprêt, Vitaly Margulis, Michael Rink, Malte Rieken, Lukas Kenner, Martin Susani, Loidl Wolgang, Shahrokh F. Shariat. Role of survivin expression in predicting biochemical recurrence after radical prostatectomy: a multi‐institutional study. BJU International 2017; 119(2) doi: 10.1111/bju.13472
|
| 4 |
Ashish Saxena, Mohammad Shoeb, Ravinder Tammali, Kota V. Ramana, Satish K. Srivastava. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice. Cancer Letters 2014; 355(1) doi: 10.1016/j.canlet.2014.09.006
|
| 5 |
Rohit Gundamaraju, Ravichandra Vemuri, Wai Chin Chong, Stephen Myers, Shaghayegh Norouzi, Madhur D. Shastri, Rajaraman Eri. Interplay between Endoplasmic Reticular Stress and Survivin in Colonic Epithelial Cells. Cells 2018; 7(10) doi: 10.3390/cells7100171
|
| 6 |
Dermot T. McDowell, Fraser M. Smith, John V. Reynolds, Stephen G. Maher, Collette Adida, Paul Crotty, Eoin F. Gaffney, Donal Hollywood, Brian Mehigan, Richard B. Stephens, M. J. Kennedy. Increased spontaneous apoptosis, but not survivin expression, is associated with histomorphologic response to neoadjuvant chemoradiation in rectal cancer. International Journal of Colorectal Disease 2009; 24(11) doi: 10.1007/s00384-009-0755-6
|
| 7 |
Sunetra Ray, Ramasamy Paulmurugan, Manish R Patel, Byeong C Ahn, Lily Wu, Michael Carey, Sanjiv S Gambhir. Noninvasive Imaging of Therapeutic Gene Expression Using a Bidirectional Transcriptional Amplification Strategy. Molecular Therapy 2008; 16(11) doi: 10.1038/mt.2008.180
|
| 8 |
Chao Qin, Qiang Cao, Pu Li, Xiaobing Ju, Meilin Wang, Jiawei Chen, Yilong Wu, Xiaoxin Meng, Jian Zhu, Zhengdong Zhang, Qiang Lu, Changjun Yin, Amanda Ewart Toland. Functional Promoter -31G>C Variant in Survivin Gene Is Associated with Risk and Progression of Renal Cell Cancer in a Chinese Population. PLoS ONE 2012; 7(1) doi: 10.1371/journal.pone.0028829
|
| 9 |
TianDuo Wang, Yuanxin Chen, John. A. Ronald. A novel approach for assessment of prostate cancer aggressiveness using survivin-driven tumour-activatable minicircles. Gene Therapy 2019; 26(5) doi: 10.1038/s41434-019-0067-6
|
| 10 |
Yongchuan Liao, Hao Zeng, Xiaojie Wang, Ying Huang, Ni Chen, Bo Ge, Li Tang, Qinli Luo. Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland. Experimental Eye Research 2009; 88(1) doi: 10.1016/j.exer.2008.09.015
|
| 11 |
Wencke Reineking, Ida E. Schauerte, Johannes Junginger, Marion Hewicker-Trautwein. Sox9, Hopx, and survivin and tuft cell marker DCLK1 expression in normal canine intestine and in intestinal adenoma and adenocarcinoma. Veterinary Pathology 2022; 59(3) doi: 10.1177/03009858221079666
|
| 12 |
Tatyana Zykova, Feng Zhu, Lei Wang, Haitao Li, Do Young Lim, Ke Yao, Eunmiri Roh, Sang-Pil Yoon, Hong-Gyum Kim, Ki Beom Bae, Weihong Wen, Seung Ho Shin, Janos Nadas, Yan Li, Weiya Ma, Ann M. Bode, Zigang Dong. Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics 2018; 17(5) doi: 10.1158/1535-7163.MCT-17-0628
|
| 13 |
M. Grudzinska, K. Lomperta, K. Jakubowska, P. Samocik, K. Jarząbek, L. Kanczuga-Koda, A. Wincewicz, M. Koda. The oncoprotein HBXIP – its functions and roles in oncogenesis. Progress in Health Sciences 2018; 8(2) doi: 10.5604/01.3001.0012.8350
|
| 14 |
Quan-Xing Ge, Yu-Yuan Li, Yu-Qiang Nie, Wen-Ge Zuo, Yan-Lei Du. Expression of survivin and its four splice variants in colorectal cancer and its clinical significances. Medical Oncology 2013; 30(2) doi: 10.1007/s12032-013-0535-6
|
| 15 |
Alfred King-Yin Lam, Said Saleh, Robert Anthony Smith, Yik-Hong Ho. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity. Human Pathology 2008; 39(8) doi: 10.1016/j.humpath.2008.01.001
|
| 16 |
Won Jun Sohn, Jung Won Lee, Dong-Guk Park. Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells. Journal of the Korean Society of Coloproctology 2010; 26(4) doi: 10.3393/jksc.2010.26.4.246
|
| 17 |
Jaya Nigam, Abhijit Chandra, Hasan Raza Kazmi, Devendra Parmar, Devendra Singh, Vishal Gupta. Prognostic significance of survivin in resected gallbladder cancer. Journal of Surgical Research 2015; 194(1) doi: 10.1016/j.jss.2014.07.054
|
| 18 |
Muhammad Wasif Saif, Antonis Zalonis, Kostas Syrigos. The clinical significance of autoantibodies in gastrointestinal malignancies: an overview. Expert Opinion on Biological Therapy 2007; 7(4) doi: 10.1517/14712598.7.4.493
|
| 19 |
Liliana Cortés‑Ballinas, Tania López‑Pérez, Leticia Rocha‑zavaleta. STAT3 and the STAT3‑regulated inhibitor of apoptosis protein survivin as potential therapeutic targets in colorectal cancer (Review). Biomedical Reports 2024; 21(6) doi: 10.3892/br.2024.1863
|
| 20 |
B-C Ahn, J A Ronald, Y I Kim, R Katzenberg, A Singh, R Paulmurugan, S Ray, L V Hofmann, S S Gambhir. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector. Gene Therapy 2011; 18(6) doi: 10.1038/gt.2011.5
|
| 21 |
JingMing Guan, RuiBo Zhao, XueYan Zhang, YanQiu Cheng, YuDong Guo, LiYan Wang, LiNa Mi, Fei Liu, Xiao Ma, BaoJie Li. Chicken Skin Mucosa Surrounding Adult Colorectal Adenomas is a Risk Factor for Carcinogenesis. American Journal of Clinical Oncology 2012; 35(6) doi: 10.1097/COC.0b013e31821dedf7
|
| 22 |
Shang-mian Yie, Be Lou, Shang-rong Ye, Mei Cao, Xu He, Ping Li, Kang Hu, Lin Rao, Sheng-min Wu, Hai-bo Xiao, En Gao. Detection of Survivin-Expressing Circulating Cancer Cells (CCCs) in Peripheral Blood of Patients with Gastric and Colorectal Cancer Reveals High Risks of Relapse. Annals of Surgical Oncology 2008; 15(11) doi: 10.1245/s10434-008-0069-x
|
| 23 |
Gyu-Seok Cho, Tae Sung Ahn, Dongjun Jeong, Jae-Jun Kim, Chang-Jin Kim, Hyun-Deuk Cho, Dong-Kook Park, Moo-Jun Baek. Expression of the survivin-2B splice variant related to the progression of colorectal carcinoma. Journal of the Korean Surgical Society 2011; 80(6) doi: 10.4174/jkss.2011.80.6.404
|
| 24 |
Christine E. Horak, Julie L. Bronder, Amina Bouadis, Patricia S. Steeg. Apoptosis, Cell Signaling, and Human Diseases. 2007; doi: 10.1007/978-1-59745-200-7_3
|
| 25 |
F Li. Role of survivin and its splice variants in tumorigenesis. British Journal of Cancer 2005; 92(2) doi: 10.1038/sj.bjc.6602340
|
| 26 |
Vergara-Castañeda Haydé, Guevara-González Ramón, Guevara-Olvera Lorenzo, Oomah B. Dave, Reynoso-Camacho Rosalía, Wiersma Paul, Loarca-Piña Guadalupe. Non-digestible fraction of beans (Phaseolus vulgarisL.) modulates signalling pathway genes at an early stage of colon cancer in Sprague–Dawley rats. British Journal of Nutrition 2012; 108(S1) doi: 10.1017/S0007114512000785
|
| 27 |
Eman El Zeneini, Sarah Kamel, Mahmoud El-Meteini, Asma Amleh. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cells. Oncology Reports 2017; 37(3) doi: 10.3892/or.2017.5390
|
| 28 |
Yaoquan Cao, Haibo Tang, Guohui Wang, Pengzhou Li, Zhi Song, Weizheng Li, Xulong Sun, Xiaoxiao Zhong, Qianqian Yu, Shaihong Zhu, Liyong Zhu. Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01622-8
|
| 29 |
Nanae Harashima, Keizo Takenaga, Miho Akimoto, Mamoru Harada. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Oncotarget 2017; 8(26) doi: 10.18632/oncotarget.17157
|
| 30 |
Peter C. Konturek, Kazimierz Rembiasz, Grzegorz Burnat, Stanisław J. Konturek, Marcin Tusinela, Władysław Bielanski, Jens Rehfeld, Danuta Karcz, Eckhart Hahn. Effects of Cyclooxygenase-2 Inhibition on Serum and Tumor Gastrins and Expression of Apoptosis-Related Proteins in Colorectal Cancer. Digestive Diseases and Sciences 2006; 51(4) doi: 10.1007/s10620-006-3206-z
|
| 31 |
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Molecular Medicine Reports 2013; 7(3) doi: 10.3892/mmr.2012.1247
|
| 32 |
John A. Ronald, Hui-Yen Chuang, Anca Dragulescu-Andrasi, Sharon S. Hori, Sanjiv S. Gambhir. Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker. Proceedings of the National Academy of Sciences 2015; 112(10) doi: 10.1073/pnas.1414156112
|
| 33 |
Woong Na, Se Min Jang, Young Jin Jun, Young Soo Song, Ki‐Seok Jang, Kang Hong Lee, Kyeong Geun Lee, Hong Xiu Han, Seung Sam Paik. Clinicopathologic significance of survivin expression in colorectal adenocarcinoma. Basic and Applied Pathology 2009; 2(3) doi: 10.1111/j.1755-9294.2009.01049.x
|
| 34 |
Manikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, Larisa Gheber, Gilead Raday, Varda Shoshan-Barmatz. Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects. Molecular Therapy Oncology 2026; 34(1) doi: 10.1016/j.omton.2025.201123
|